TFAM and Alzheimer disease: Spanish AD patients also showed a significant reduction in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and mitochondrial transcription factor A (TFAM) levels compared to controls, while only TFAM levels were decreased in MCI Spanish patients.